Attached files
file | filename |
---|---|
EX-23.1 - CONSENT OF ERNST & YOUNG LLP - AVEO PHARMACEUTICALS, INC. | d264862dex231.htm |
EX-32.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC. | d264862dex322.htm |
EX-21.1 - SUBSIDIARIES - AVEO PHARMACEUTICALS, INC. | d264862dex211.htm |
EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC. | d264862dex321.htm |
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC. | d264862dex312.htm |
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC. | d264862dex311.htm |
EX-10.8 - FORM OF RESTRICTED STOCK AGREEMENT - AVEO PHARMACEUTICALS, INC. | d264862dex108.htm |
EX-10.25 - AMENDMENT NO. 1 TO LOAN & SECURITY AGREEMENT - AVEO PHARMACEUTICALS, INC. | d264862dex1025.htm |
EX-10.29 - FIRST AMENDMENT TO SUBLEASE - AVEO PHARMACEUTICALS, INC. | d264862dex1029.htm |
EXCEL - IDEA: XBRL DOCUMENT - AVEO PHARMACEUTICALS, INC. | Financial_Report.xls |
10-K - FORM 10-K - AVEO PHARMACEUTICALS, INC. | d264862d10k.htm |
Exhibit 10.23
AVEO Pharmaceuticals, Inc. 75 Sidney Street Cambridge, MA 02139
www.aveopharma.com |
October 31, 2011
Raju Kucherlapati, PhD
6 Wildflower Lane
Weston, MA 02493
Re: Consulting and Scientific Advisory Board Agreement by and between Raju Kucherlapati, PhD and AVEO Pharmaceuticals, Inc. effective as of January 1, 2010 (the Agreement)
Dear Dr. Kucherlapati,
It is hereby agreed that Section 2 of the Agreement shall be amended to extend the Consultation Period through and including December 31, 2013 unless sooner terminated in accordance with Section 11 of the Agreement. All other terms and obligations under the Agreement shall remain the same.
Sincerely, |
/s/ Murray O. Robinson |
Murray O. Robinson, PhD |
Senior Vice President, Translational Research |
Chair of the Scientific Advisory Board |
Agreed and Acknowledged: | ||||||
/s/ Raju Kucherlapati |
November 3, 2011 |
|||||
Raju Kucherlapati, PhD | Date |